Synopsis:
Intramuscular penicillin prophylaxis, despite commonly
perceived challenges, is a practical option which can
contribute to better patient compliance and thus
significantly impact global rates of invasive pneumococcal
disease and its complications in children
with SCD and other similar conditions.